News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
82 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37190)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53929)
2023 (42568)
2024 (38485)
2025 (21072)
Month
January (4345)
February (4356)
March (4476)
April (4722)
May (4999)
June (4103)
July (3643)
August (3330)
September (4039)
October (5056)
November (4470)
December (3799)
Day
1 (179)
2 (151)
3 (82)
4 (11)
5 (19)
6 (2)
7 (1)
8 (200)
9 (246)
10 (182)
11 (223)
12 (56)
13 (2)
14 (10)
15 (152)
16 (255)
17 (188)
18 (170)
19 (74)
20 (3)
21 (9)
22 (155)
23 (232)
24 (190)
25 (213)
26 (67)
27 (4)
28 (5)
29 (170)
30 (200)
31 (192)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
Policy
British Researchers Blocked as the Result of Brexit
According to a University College London (UCL) report, British researchers are being shut out of major European research partnerships because of concerns over a no-deal Brexit.
July 3, 2019
·
3 min read
·
Mark Terry
Drug Development
Research Roundup: Gut Bacteria to Prevent and Reverse Food Allergies and More
Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.
July 3, 2019
·
4 min read
·
Mark Terry
Bio NC
U.S. Companies Continue to Pay More in Healthcare as the Cost of Drugs Keeps Rising
The rising cost of healthcare has been a hot topic of discussion as of late throughout the United States, with many presidential candidates using it as a selling point of their campaign.
July 3, 2019
·
3 min read
·
Sasha Mortimer
Career Advice
Health Insurance 101 for Life Science Professionals
A recent BioSpace survey found that health insurance is one of the top considerations of life science professionals willing to relocate for a job. To learn more, we interviewed Carrie Richards Leary, a health insurance benefits professional.
July 3, 2019
·
4 min read
·
Porschia Parker
Drug Development
MorphoSys’s Licensing Partner GSK Initiates Phase 3 Clinical Program With Otilimab (MOR103/GSK3196165) in Rheumatoid Arthritis; MorphoSys Updates its Financial Guidance for 2019
MorphoSys AG announced that its licensing partner GSK reported in a press release earlier the start of a phase 3 clinical development program with otilimab in rheumatoid arthritis.
July 3, 2019
·
4 min read
FDA
U.S. Pharma and Biotech Companies Develop Therapies that Lead to ‘Health Independence.’
As fireworks illuminate the night skies across the United States this weekend in celebration of Independence Day, BioSpace takes a look at some of the highlights of the pharma industry from the first half of 2019 and earlier that provides millions of patients with the independence of health.
July 3, 2019
·
4 min read
·
Alex Keown
Business
Nosopharm and Evotec enter into collaboration to accelerate development of novel antibiotics
Nosopharm and Evotec SE announce their partnership aimed at advancing Nosopharm’s lead candidate, NOSO-502, to the clinical stage, as well as developing a second-generation Odilorhabdin drug candidate.
July 3, 2019
·
4 min read
Deals
Evotec completes acquisition of Just Biotherapeutics
Evotec SE announced that the strategic transaction to acquire Just Biotherapeutics, signed on 20 May 2019, has been completed.
July 3, 2019
·
5 min read
Business
Confo Therapeutics and DyNAbind announce drug discovery collaboration to identify novel GPCR-modulating compounds
Confo Therapeutics, an emerging drug discovery company, and DyNAbind GmbH announce a drug discovery collaboration on an undisclosed G-protein coupled receptor.
July 3, 2019
·
3 min read
Drug Development
Auris Medical Completes Enrollment of Phase 1b Proof-Of-Concept Trial of AM-201 in Antipsychotic-Induced Weight Gain
Auris Medical Holding Ltd. announced that it has completed enrollment in its Phase 1b proof-of-concept trial of AM-201, the Company’s investigational drug for the prevention of antipsychotic-induced weight gain and somnolence.
July 3, 2019
·
5 min read
Previous
2 of 9
Next